Janey Watts, DO
Family Medicine · Pikeville, KYNPI 1275885832
Payments from drug & device makers
Across 187 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- AbbVie$1K
- Daiichi Sankyo Inc.$468
- Mayne Pharma Commercial LLC$376
- ANI Pharmaceuticals, Inc.$138
- Lilly USA, LLC$84
- plus $999 from 26 others
What the payments were for
- Travel & lodging$86018%
- Food & beverage$3,78980%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $1,424 |
| AbbVie(2 entities) | 77 | $1,220 |
| Daiichi Sankyo Inc. | 29 | $468 |
| Mayne Pharma Commercial LLC | 2 | $376 |
| ANI Pharmaceuticals, Inc. | 8 | $138 |
| Lilly USA, LLC | 4 | $84 |
| Johnson & Johnson | 2 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $75 |
| Shield Therapeutics Inc | 2 | $74 |
| GSK | 4 | $61 |
| Myovant Sciences Inc. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Exeltis, USA Inc. | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 3 | $49 |
| Pfizer | 3 | $49 |
| Sobi, Inc | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Novartis | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Abbott | 2 | $33 |
| Novo Nordisk | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Merck | 2 | $27 |
| Boston Scientific | 1 | $24 |
| Amgen | 1 | $21 |
| Gynesonics, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,708 in reported general payments places this provider in the 80th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 102 | $111,559 |
| OzempicSemaglutide | 56 | $52,339 |
| FarxigaDapagliflozin Propanediol | 57 | $42,802 |
| JanuviaSitagliptin Phosphate | 26 | $32,379 |
| JardianceEmpagliflozin | 45 | $31,695 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $22,500 |
| LinzessLinaclotide | 25 | $22,140 |
| XareltoRivaroxaban | 24 | $20,414 |
| EntrestoSacubitril/Valsartan | 17 | $16,115 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $15,068 |
| EliquisApixaban | 22 | $14,122 |
| TrulicityDulaglutide | 12 | $11,625 |
| JanumetSitagliptin Phos/Metformin Hcl | 17 | $9,679 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 220 | $8,435 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 17 | $7,688 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $84 | $123,184114 claims |
| Novo NordiskOzempic | $32 | $52,33956 claims |
| MerckJanuvia, Janumet | $27 | $42,05843 claims |
| AbbVieLinzess, Synthroid | $1,220 | $25,71277 claims |
| GSKTrelegy Ellipta | $61 | $22,50035 claims |
| Johnson & JohnsonXarelto | $80 | $20,41424 claims |
| NovartisEntresto | $36 | $16,11517 claims |
| PfizerEliquis | $49 | $14,12222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Pikeville
- Suzanne FordPikeville$19K
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.